ACE2 and lung disorder: The very first study using this strain of ACE2 KO mice in pulmonary disease settings was reported by Kuba et al.39, where the authors infected the KO mice and control counterparts with clinical isolates of SARS-CoV and found that ACE2 KO mice were resistant to SARS-CoV infection.